Top Markets
#1 TENDIES TENDIES +42.50%
#2 ICON ICON +27.31%
#3 Threshold Network Threshold Network +26.12%
#4 Cash Cat Cash Cat +25.97%
#5 Asteroid Shiba Asteroid Shiba +17.20%
#6 OSK OSK +15.67%
#7 MarsCoin MarsCoin +12.17%
#8 Ape and Pepe Ape and Pepe +9.71%
#9 Pirate Chain Pirate Chain +9.26%
#10 Kite Kite +9.02%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Oryzon Genomics S.A. Oryzon Genomics S.A.

Oryzon Genomics S.A.

ORY
Rank in Stocks #16839
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Share Price
$3.31
Last synced: 2026-09-01
Market Cap
$271.03M
Change (1 day)
-0.36%
Change (1 year)
8.04%
Country
ES
Trade Oryzon Genomics S.A. (ORY)

Category

Healthcare
Stock price history for Oryzon Genomics S.A. (ORY)
Highest end of day price: $3.31 on 2026-09-01

Lowest end of day price: $4.05 on 2015-12-01
Stock price history of Oryzon Genomics S.A. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -2.99%
2025 127.05%
2024 -28.98%
2023 -7.72%
2022 -20.86%
2021 -17.47%
2020 14.60%
2019 14.88%
2018 -16.03%
2017 -30.04%
2016 21.22%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH